For those desiring to outshine the market, the strategic selection of individual stocks is paramount. Well-chosen stocks have the potential to substantially boost your wealth.
The price of PDS Biotechnology Corporation (NASDAQ: PDSB) closed at $2.64 in the last session, down -8.79% from day before closing price of $2.90. In other words, the price has decreased by -$8.79 from its previous closing price. On the day, 0.88 million shares were traded. PDSB stock price reached its highest trading level at $2.915 during the session, while it also had its lowest trading level at $2.59.
Ratios:
We take a closer look at PDSB’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.33 and its Current Ratio is at 4.33. In the meantime, Its Debt-to-Equity ratio is 0.91 whereas as Long-Term Debt/Eq ratio is at 0.75.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, B. Riley Securities on November 01, 2022, initiated with a Buy rating and assigned the stock a target price of $10.
On June 28, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $25.
H.C. Wainwright Upgraded its Neutral to Buy on November 10, 2020, while the target price for the stock was maintained at $6.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PDSB now has a Market Capitalization of 97016744 and an Enterprise Value of 64307784.
Stock Price History:
The Beta on a monthly basis for PDSB is 1.81, which has changed by -0.5821485 over the last 52 weeks, in comparison to a change of 0.2006725 over the same period for the S&P500. Over the past 52 weeks, PDSB has reached a high of $10.27, while it has fallen to a 52-week low of $2.68. The 50-Day Moving Average of the stock is -43.57%, while the 200-Day Moving Average is calculated to be -47.77%.
Shares Statistics:
According to the various share statistics, PDSB traded on average about 927.26K shares per day over the past 3-months and 791670 shares per day over the past 10 days. A total of 36.68M shares are outstanding, with a floating share count of 34.89M. Insiders hold about 4.89% of the company’s shares, while institutions hold 22.52% stake in the company. Shares short for PDSB as of 1711584000 were 6152075 with a Short Ratio of 6.63, compared to 1709164800 on 5033290. Therefore, it implies a Short% of Shares Outstanding of 6152075 and a Short% of Float of 17.559999.
Earnings Estimates
The current rating of PDS Biotechnology Corporation (PDSB) is the result of assessments by 6 analysts actively engaged in evaluating its market dynamics.On average, analysts expect EPS of -$0.37 for the current quarter, with a high estimate of -$0.28 and a low estimate of -$0.45, while EPS last year was -$0.32. The consensus estimate for the next quarter is -$0.36, with high estimates of -$0.28 and low estimates of -$0.45.
Analysts are recommending an EPS of between -$1.11 and -$1.75 for the fiscal current year, implying an average EPS of -$1.48. EPS for the following year is -$1.61, with 5 analysts recommending between -$1.3 and -$1.97.
